KIMMTRAK Receives NHS Funding for Uveal Melanoma Treatment in England
Durvalumab Boosts Survival in Advanced Endometrial Cancer
G-BA Excludes Six Medical Products from Reimbursement List
Dupilumab Evaluated for New Childhood Eosinophilic Esophagitis Treatment
Transparency Council Approves Pomalidomide for Expanded Myeloma Treatment
Daratumumab Undergoes New Benefit Assessment for Multiple Myeloma Treatment
G-BA Suspends Carvykti’s Benefit Assessment Over Revenue Threshold
Zai Lab Secures NRDL Inclusion for AUGTYRO and Enhances China’s Treatment Landscape
Pharmac Switches Oestradiol Patch Brand to Address Shortages
G-BA Integrates New Biosimilars into German Drug Regulations
European Agency Launches New Platform to Monitor Drug Shortages
G-BA Aligns ATMP Guidelines with 2025 ICD and OPS Codes
New Approval Forms for ADHD Medications Begin December 2024
Germany Evaluates Cost-Effectiveness of Orphan Antibiotic Aztreonam/Avibactam
G-BA Reviews Phonocardiography’s Role in CHD Diagnosis